News

VTE risk models target a formidable surgery foe


 

AT THE NORTHWESTERN VASCULAR SYMPOSIUM

References

Scarborough model. Finally, in an attempt to develop a RAM specific to vascular surgery patients, Dr. John Scarborough and colleagues examined 6,035 patients undergoing open AAA repair in the NSQIP database. The 30-day VTE rate was 2.4% for the entire cohort. Eight independent perioperative risk factors were identified and used to create a nonweighted scoring system (J. Am. Coll. Surg. 2012;214:620-6).

Overall, 65% of patients had 0-1 risk factor and a VTE incidence of 1.5%, while 15% had 3 or more risk factors and a VTE incidence of 6.1%. The Scarborough model has good risk stratification, Dr. Kibbe said, but it is limited by the aforementioned criticisms regarding the NSQIP database, and it also needs prospective validation.

“We all know that proper VTE prophylaxis is very important for our patients; but we need mechanisms by which the attention given to this need for prophylaxis, which is a lot, is turned into proper implementation,” she said.

For Dr. Kibbe and her colleagues, proper implementation meant developing a RAM that was incorporated into the electronic medical record system for all surgical patients at the Jesse Brown VA Medical Center in Chicago. Clinicians were prompted to complete the RAM upon placing orders for preanesthesia testing clearance, and the clinical decision support system would provide a recommended prophylaxis regimen and easily selected electronic orders that could be signed.

A pre- and postimplementation analysis involving 400 consecutive patients revealed an 82% increase in patients with preoperative VTE prophylaxis ordered (22% vs. 40%), a 75% decrease in inappropriate cancellation of orders more than 12 hours before surgery (37% vs. 9%), and a nearly sevenfold increase in the number of patients receiving pharmacologic and mechanical prophylaxis (5% vs. 32%), she said. There was an 80% and 36% decline in DVT rates at 30 and 90 days postoperative, but event rates were too low to detect a significant difference (J. Vasc. Surg. 2010;51:648-54).

Dr. Kibbe reported having no financial disclosures.

pwendling@frontlinemedcom.com

Pages

Recommended Reading

STEMI: Prereperfusion IV metoprolol shows long-term benefits
MDedge Cardiology
VIDEO: Consider cognitive function in elderly before surgery
MDedge Cardiology
Guideline adjusts perioperative cardiac care in noncardiac surgery
MDedge Cardiology
Medical consultation rates for surgical cases vary
MDedge Cardiology
COPPS-2 curtails colchicine enthusiasm in cardiac surgery
MDedge Cardiology
High-dose statins don’t prevent postop AF
MDedge Cardiology
Fenoldopam missed renal endpoint, caused hypotension in cardiac surgery patients
MDedge Cardiology
VIDEO: Bioabsorbable polymer stents offer improved deliverability
MDedge Cardiology
CABG plus mitral repair put under spotlight
MDedge Cardiology
ICD lead extraction complication rates warrant surgical backup
MDedge Cardiology